Related Experiment Video
Updated: Jul 19, 2026

09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Comparative proteomic profiles of meningioma subtypes
Hiroaki Okamoto1, Jie Li, Alexander O Vortmeyer
1Surgical Neurology Branch and Protein/Peptide Sequencing Facility, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland 20892, USA.
Cancer Research
|October 19, 2006
Summary
Researchers identified unique protein expression patterns in different grades of meningiomas. This proteomic analysis helps distinguish benign, atypical, and anaplastic tumors, improving diagnosis and understanding of meningioma progression.
Area of Science:
- Neuro-oncology
- Proteomics
- Molecular Pathology
Background:
- Meningiomas are tumors arising from the meninges, classified into WHO grades 1 (benign), 2 (atypical), and 3 (anaplastic).
- Atypical and anaplastic meningiomas have higher recurrence and mortality rates than benign types.
- Distinguishing between meningioma grades based solely on morphology can be challenging.
Purpose of the Study:
- To identify distinct proteomic profiles for each WHO grade of meningioma.
- To discover specific proteins that can differentiate between benign, atypical, and anaplastic meningiomas.
- To explore the diagnostic and prognostic implications of these proteomic differences.
Main Methods:
- Selective tissue microdissection of 24 human meningiomas.
- Two-dimensional gel electrophoresis for protein expression analysis.
- Protein identification via sequencing, confirmed by Western blotting and immunohistochemistry.
Main Results:
- Proteomic analysis revealed unique expression patterns for WHO grade 1, 2, and 3 meningiomas.
- Identified 24 proteins that distinguish between the different meningioma subtypes.
- Fifteen proteins differentiated benign from atypical meningiomas, and nine differentiated atypical from anaplastic meningiomas.
Conclusions:
- Established differential proteomic profiles for characterizing and distinguishing meningioma grades.
- The identified proteins and profiles enhance understanding of meningioma pathogenesis.
- These findings have significant implications for meningioma diagnosis, prognosis, and treatment strategies.
